E/C/F/TDF + COBI + ATV + DRV + NRTI
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acquired Immunodeficiency Syndrome
Conditions
Acquired Immunodeficiency Syndrome, HIV Infections
Trial Timeline
May 1, 2011 → Feb 1, 2015
NCT ID
NCT01363011About E/C/F/TDF + COBI + ATV + DRV + NRTI
E/C/F/TDF + COBI + ATV + DRV + NRTI is a phase 3 stage product being developed by Gilead Sciences for Acquired Immunodeficiency Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT01363011. Target conditions include Acquired Immunodeficiency Syndrome, HIV Infections.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01363011 | Phase 3 | Completed |
Competing Products
20 competing products in Acquired Immunodeficiency Syndrome